End of the road

http://www.fool.com/investing/general/2013/10/18/end-of-the-road-for-ariad.aspx

Ariad is going the way of the dinosaur

 

JPMorgan polled 50 hematologists and oncologists after the news broke about the FDA's clinical hold on Inclusig. Most of those contacted don't plan to change prescribing patterns. Based on those results, the investment firm concluded that physicians "may be far less spooked by the safety update than the investor community."

 

nice try loser! that was yesterday's news before trial halted news this morning. No confidence in the drug to beat Gleevec! BMS & Novartis are spreading the word!

 

http://seekingalpha.com/article/1757382-is-ariad-pharmaceuticals-salvageable?source=email_rt_article_readmore

 

Help! I've fallen and I can't get up!

 

silly child the reps at ARIAD won't need help...we are leaders and risk takers. we land on our feet; we have the respect of our customers and respect the patients we help. We have something you will never have.... integrity, intelligence and strength Go back to eating glue while we pave the future.

 

http://seekingalpha.com/news-article/7927192-amarin-announces-plans-to-reduce-expenses-by-decreasing-staff-following-recent-fda-advisory-committee-vote

Just change the name from Amarin to Ariad and you can see the future press release from Harv...

 

Iclusig will limp along as a last ditch drug for resistant disease, but that's it. Company tanks, drug is sold cheap, fade to black.

 

maybe will be bought up?

 

Heard Schampy trying to get old job back @ Incyte with their new expansion!

 

Yes, by Novartis!

 

stock bouncing back? still too low!!!!!!

 

Lol

 

If I could buy him for what he is worth...and sell him for what He thinks He is worth...I would be a multi-millionaire (starting from $0!).

 

Time to buy some stocks!!! FDA granting us front line indication next week.

 

Doesn't look good for the sales and marketing teams. Ariad announced today that based in discussions with FDA they will immediately cease selling Iclusig.

This is greater impact to the company than halting the EPIC clinical trail. Cash flow will may not be enough to sustain the company.

 

Sorry everyone for my mistakes but you will get a big severance. Harvey

 

Lol!

 

Severance? You will get a can of soda from the break room

 

Big smile on my face!

-competitor